skip navigation

Skip Nav

Clinical Guidelines Portal

Clinical Guidelines Portal

Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents

Appendix C: Panel Roster and Financial Disclosures


(Last updated: November 1, 2012; last reviewed: November 1, 2012)

Disseminated Mycobacterium avium Complex Disease
Member Financial Disclosure
Company Relationship
Cohn, David University of Colorado School of Medicine None N/A
Currier, Judith
University of California, Los Angeles
Achillion DSMB Member
EMD Seronon Advisory Board
Gilead Consultant
GlaxoSmithKline Honoraria
Janssen-Cilag Honoraria, Travel Support
Koronis DSMB Member
Merck Advisory Board, Research Support
Pfizer Advisory Board
Schering-Plough Research Support
Tibotec Advisory Support, Research Support, Travel Support
Dorman, Susan Johns Hopkins University Bill and Melinda Gates Foundation Research Support
FDA Research Support
NIH Research Support
Gordin, Fred*
Veterans Affairs Medical Center; Washington , DC
None N/A
Horsburgh, C. Robert Boston University Bill and Melinda Gates Foundation Travel Support
CDC Research Support
Medical Research Council (UK) Travel Support
NIH Research Support
* Group lead

Note: Members were asked to disclose all relationships from 24 months before the writing panel convened. The period of reporting was from June 1, 2008, through November 1, 2012.

Back to Top